Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts
Open Access
- 1 May 2011
- journal article
- clinical trial
- Published by Elsevier in International Psychogeriatrics
- Vol. 23 (4) , 539-545
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCTTrials, 2009
- Review: Therapy for Alzheimer's disease: how effective are current treatments?Therapeutic Advances in Neurological Disorders, 2009
- Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementiaThe American Journal of Geriatric Pharmacotherapy, 2009
- The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohortInternational Psychogeriatrics, 2008
- A Population‐Based Study of Cholinesterase Inhibitor Use for DementiaJournal of the American Geriatrics Society, 2007
- The Use of a Cholinesterase Inhibitor Review Committee in Long-Term CareJournal of the American Medical Directors Association, 2007
- Efficacy and safety of donepezil over 3 years: an open‐label, multicentre study in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2007
- Naturalistic audit of NICE criteria for the use of cholinesterase inhibitorsPsychiatric Bulletin, 2005
- Effect of Antipsychotic Withdrawal on Behavior and Sleep/Wake Activity in Nursing Home Residents with Dementia: A Randomized, Placebo‐Controlled, Double‐Blinded Study The Bergen District Nursing Home StudyJournal of the American Geriatrics Society, 2004
- Discontinuation syndrome following donepezil cessationInternational Journal of Geriatric Psychiatry, 2003